CCCC
C4 TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
CCCC vs peer average
54/100
CCCC vs. peer average (C vs. C)
Grade spread
A 1 · B 2 · C 3 · D 3 · F 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
REPL is the first available peer comparator.
Loose peer as a small-cap clinical biotech where valuation is still dominated by pipeline execution and catalyst timing rather than current revenue; useful for framing binary readout risk and financing sensitivity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CCCC
C4 Therapeutics
REPL
Replimune Group
Grade
C
D
Momentum
79
99
Value
41
41
Sentiment
36
1
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs REPL
CCCC / REPL
Grade Position
In line
CCCC vs. peer average (C vs. C)
54/100
Momentum
79
REPLValue
41
CCCCSentiment
36
CCCCRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CCCC
REPL is the first peer returned for this comparison set.